Primary central nervous system lymphoma in a patient treated with natalizumab

Ann Neurol. 2011 Jun;69(6):1060-1; author reply 1061-2. doi: 10.1002/ana.22296. Epub 2011 Feb 16.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Brain / pathology
  • Central Nervous System Neoplasms / drug therapy*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphoma / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Natalizumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Natalizumab